1. Home
  2. IPSC vs GIFT Comparison

IPSC vs GIFT Comparison

Compare IPSC & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • GIFT
  • Stock Information
  • Founded
  • IPSC 2019
  • GIFT 1999
  • Country
  • IPSC United States
  • GIFT United States
  • Employees
  • IPSC N/A
  • GIFT N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • GIFT Catalog/Specialty Distribution
  • Sector
  • IPSC Health Care
  • GIFT Consumer Discretionary
  • Exchange
  • IPSC Nasdaq
  • GIFT Nasdaq
  • Market Cap
  • IPSC 48.2M
  • GIFT 53.3M
  • IPO Year
  • IPSC 2021
  • GIFT N/A
  • Fundamental
  • Price
  • IPSC $0.53
  • GIFT $1.75
  • Analyst Decision
  • IPSC Strong Buy
  • GIFT Strong Buy
  • Analyst Count
  • IPSC 5
  • GIFT 1
  • Target Price
  • IPSC $3.33
  • GIFT $4.00
  • AVG Volume (30 Days)
  • IPSC 719.1K
  • GIFT 34.6K
  • Earning Date
  • IPSC 05-15-2025
  • GIFT 05-13-2025
  • Dividend Yield
  • IPSC N/A
  • GIFT N/A
  • EPS Growth
  • IPSC N/A
  • GIFT N/A
  • EPS
  • IPSC N/A
  • GIFT N/A
  • Revenue
  • IPSC $114,898,000.00
  • GIFT $89,689,155.00
  • Revenue This Year
  • IPSC $833.10
  • GIFT $26.85
  • Revenue Next Year
  • IPSC N/A
  • GIFT N/A
  • P/E Ratio
  • IPSC N/A
  • GIFT N/A
  • Revenue Growth
  • IPSC 8286.72
  • GIFT 6.13
  • 52 Week Low
  • IPSC $0.34
  • GIFT $0.50
  • 52 Week High
  • IPSC $3.46
  • GIFT $4.27
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 46.73
  • GIFT N/A
  • Support Level
  • IPSC $0.48
  • GIFT N/A
  • Resistance Level
  • IPSC $0.59
  • GIFT N/A
  • Average True Range (ATR)
  • IPSC 0.04
  • GIFT 0.00
  • MACD
  • IPSC -0.00
  • GIFT 0.00
  • Stochastic Oscillator
  • IPSC 34.62
  • GIFT 0.00

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About GIFT RDE Inc. Common Stock

Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.

Share on Social Networks: